Navigation Links
Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Date:6/6/2008

"We are choosing not to advance the SYI-2074 program in the very competitive area of acute coronary syndrome at this time, in the absence of stronger surrogate markers of efficacy," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista Therapeutics.

"We are pleased to have established correlation between increased plasma isoprostanes and haptoglobin type, as we believe this further validates the biology underlying our proprietary haptoglobin test. Haptoglobin typing has been used in studies that have evaluated more than 20,000 patients, and researchers have demonstrated that Hp2-2 patients with diabetes are at high risk for myocardial infarction, heart failure and stroke. To that end, our diagnostic test is on track to be available commercially in the second quarter of 2009. Further, we are planning to submit a kit measuring CML (carboxy-methyl-lysine), another increasingly well-validated, cardiovascular biomarker, for FDA marketing clearance in 2009," Dr. Berkowitz continued. "We are also moving forward with our alagebrium program, which began enrollment last month in a Phase 2 study for diastolic heart failure in Haptoglobin 2-2 diabetic patients, which complements a second Phase 2 study in systolic heart failure, begun last November and almost half enrolled."

About the Studies

Trial 201 was a Phase 2, placebo-controlled, dose-escalation study in which patients with diabetes and Hp2-2 were given SYI-2074 at 20, 40 or 80mg or placebo three times daily for 28 days. The study evaluated the impact of these doses on inflammatory biomarkers, and the quality and quantity of their cholesterol. Results found that SYI-2074 demonstrated improvement in some but not all of these biomarkers.

Trial 201a was a Phase 2, placebo-controlled sub-study of Trial 201. Patients with diabetes, meeting enrollment criteria for Trial 201 were tested for haptoglobin type. Patients with Hp2-2 or Hp1-1 were evaluated for baseline leve
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
2. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
3. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
4. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
5. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
6. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
11. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 Research ... addition of the  "North America Ultrasound Devices ... - 2019)"  report to their offering.  ... is a type of imaging. It uses ... parts and structures inside the body. Health ...
(Date:5/28/2015)... WOODLANDS, Texas , May 28, 2015   ... today that Lexicon management will present at the Jefferies ... 8:00 a.m. Eastern Time in New York ... Lexicon,s clinical development programs and milestones. A ... website at www.lexpharma.com . An archived version of ...
(Date:5/28/2015)... DEKALB, Ill. , May 28, ... of Intent to explore an affiliation with Northwestern ... KishHealth and NMHC will further define the affiliation, ... "KishHealth is recognized for their commitment ... Dean M. Harrison , President and Chief ...
Breaking Medicine Technology:North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2Lexicon To Present At The Jefferies 2015 Healthcare Conference 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3
... a wholly owned subsidiary of Mistral Ventures, Inc. ( MILV.pk ... an agreement to purchase all rights to a novel Weight ... has requested that the purchase price not be publicized. With ... loss is a booming business that continues to grow even ...
... Dr. Ira J. Haimowitz, Executive Vice President, Group Director, ... on an expert panel at the inaugural Business Analytics ... Hotel in Boston on November 16, 2011. ... features the latest business thinkers, corporate leaders, and cutting-edge ...
Cached Medicine Technology:Nature's Bioceuticals Finalizes Agreement for the Purchase of Proprietary Weight Loss Formula 2Nature's Bioceuticals Finalizes Agreement for the Purchase of Proprietary Weight Loss Formula 3Ira Haimowitz, PhD, EVP, Group Director, Intelligence and Analytics at The CementBloc, to Present at Aberdeen Group Inaugural Business Analytics Summit 2
(Date:5/28/2015)... Bayonne, NJ (PRWEB) May 28, 2015 ... has announced an exclusive deal to patients looking ... From June 1 through 30, patients will be able ... an $800 procedure, for just $600. For a three-treatment ... a fourth treatment at no cost. , Dr. Juanita ...
(Date:5/28/2015)... 28, 2015 Ross A. Clevens, MD, ... has hired Teresa Beard as the new marketing director ... Beard will oversee all marketing and promotional events for ... leading teams and developing compelling marketing strategies to achieve ... Specialists, Beard served as guest communication manager at the ...
(Date:5/28/2015)... ISMETT , a leading transplant hospital ... Sicilian economy by €132.5 million in expenditure in 2013, generated ... than €73 million by retaining patients who otherwise would have ... study by the Battelle Memorial Institute. At the same time, ... advanced health care management that is transforming Sicily into a ...
(Date:5/28/2015)... 28, 2015 The CEO and Founder ... just launched blog series which provides analysis on the ... the “R. Bruce Dalglish” profile on Blogger.com, this instructive ... Dalglish’s corporate experience. , “Throughout my business career, ... have upon the overall success of businesses,” stated R. ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
Breaking Medicine News(10 mins):Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3
... Willie Mays in the 1954 World Series as one of the greatest ... a puzzle: How does an outfielder get to the right place at ... of fans (and hundreds of thousands of YouTube viewers) saw Mays turn ... and catch the ball over his shoulder, seemingly a precise prediction of ...
... enzyme affects blood glucose levels in mice provides clues to ... of longevity and the proliferation of tumor cells. In ... , a Massachusetts General Hospital (MGH)-based team of researchers describes ... a fatal drop in blood sugar in mice by triggering ...
... with proteomic analyses of blood samples may help physicians ... many women, according to an article published in the ... . Proteomics is the study of proteins, particularly their ... fifth leading cause of cancer-related death. More than 21,500 ...
... sensor could provide fresh, inexpensive diagnosis and treatment methods ... University of Florida engineers have designed and tested versions ... glucose levels via their breath to detecting possible indicators ... are promising particularly considering that the sensor can ...
... The BC Centre for Disease Control has launched ... the pandemic H1N1 flu virus has evolved in British ... months. This project capitalizes on BC,s expertise and ... genomes from circulating influenza viruses collected in British Columbia ...
... , Housewife Hits South ... Lisa Wu Hartwell , one of the stars ...  is coming to Boca Raton, Florida .   She isn,t ... of millions of viewers. , (Photo: http://www.newscom.com/cgi-bin/prnh/20100120/DC41252 ) , (Logo: ...
Cached Medicine News:Health News:How does an outfielder know where to run for a fly ball? 2Health News:Lack of cellular enzyme triggers switch in glucose processing 2Health News:Lack of cellular enzyme triggers switch in glucose processing 3Health News:Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer 2Health News:Engineers: New sensor could help treat, combat diabetes, other diseases 2Health News:Genomic surveillance of pandemic H1N1 2Health News:Bravo's 'Real Housewife' Comes to Boca Raton, Florida 2
... The Advanced® 2020 Multi-Sample Osmometer provides ... industrial, and research settings. These results ... freezing-point method, which determines total concentration. ... on-board data management, automated sample handling, ...
... Konica Minolta/Air-Shields® JM-103 Jaundice Meter® from Drger ... that will assist you in management of ... estimate of serum bilirubin levels reported in ... other clinical signs and laboratory measurements this ...
Anti-GBM IgG Assay...
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
Medicine Products: